Neurology Advisor

FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review

The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.

US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals

By Ahmed Aboulenein WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday ...
RAPS

FDA officials look outward to improve the expedited drug approval process

International regulators take a variety of approaches to expedited drug approvals, according to a new opinion piece from leading US Food and Drug Administration (FDA) officials. Many health ...

FDA set to pilot test real-time tracking of clinical trials

The Food and Drug Administration (FDA) is set to pilot test real-time clinical trials in the hopes of expediting results and ...
Devdiscourse

FDA Transparency Under Scrutiny Amid Drug Approval Processes

The U.S. FDA's accelerated drug approval process requires greater transparency, states the Institute for Clinical and Economic Review. The pathway is key for medications targeting serious conditions ...
Medscape

In the Race to the First Psychedelic Approval, Who’s Leading?

A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
Scientific American

RFK, Jr., puts psychedelics on fast track to FDA review and approval

The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying ...